Upcoming events
Christopher Cook

Christopher Cook

Interventional cardiologist / Cardiologist
Imperial College London - London, United Kingdom

Latest contributions

New ESC/EACTS Guidelines for the management of Valvular Heart Disease (VHD)

31 Aug 2017

The new joint ESC/EACTS guidelines for the management of valvular heart disease have been hotly anticipated, with extended indications for transcutaneous aortic valve implantation (TAVI) widely tipped to be the star of the show. In comparison to 2012, where data from two randomized control trials assessing TAVI were available, outcome data from nearly six thousand patients across six randomized trials were available to the 2017 guideline writing committee. Therefore, the major challenge for this guideline was to assimilate this data and make it applicable in realworld clinical practice. In that regard, this new document has evolved beyond simple ‘guidance’ and now introduces new ‘concepts of care’ for patients with valvular heart disease.

Christopher Cook


Christopher Cook

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

28 Aug 2017

Christopher Cook


Christopher Cook

PCR @ ESC Congress 2017

We will be providing live updates on a selection of major Late Breaking Scientific Sessions of interest to Interventional Cardiologists during ESC Congress 2017.

PFO closure reduces recurrent strokes – a therapeutic promise is finally kept

22 May 2017

In patients with a patent foramen ovale (PFO) and cryptogenic stroke, percutaneous closure of the PFO has long been postulated to reduce the rate of recurrent strokes. However, up until now, trial data has failed to convincingly deliver a message of benefit for such an approach. Although the wait has been long, two recently reported trials finally seem to deliver on the therapeutic promise of PFO closure.

Frequent treatment dilemmas in coronary interventions

19 May 2017 – From EuroPCR 2017

An image is worth 1,000 words

18 May 2017 – From EuroPCR 2017

EuroPCR 2017: Antiplatelet therapy post TAVR / TAVI – What is state of the ARTE practice?

EuroPCR 2017: Impressive results for a next generation TAVR / TAVI device

FFR and diagnostic dilemma

17 May 2017 – From EuroPCR 2017

EuroPCR 2017: REPRISE III – No space for surgery in extreme risk aortic stenosis patients

EuroPCR 2017: DESSOLVE III – crystal clear benefit?

Long LAD lesion with 2 overlapped BRS

18 May 2016 – From EuroPCR 2016

Panellists: K. Al Faraidy, E. Edelman, T. Gori, D. Holmes, U. Kaul and J. Ormiston

Watch this session if you want to learn more about long LAD lesion with 2 overlapped BRS.

Clinical case

A 50-year-old male with STEMI in April 2016:

Multivessel diseasePPCI of OM1 has been doneLong lesion of LAD with 2 overlapped BRSOCT assessment
Christopher Cook


Christopher Cook
Michael Haude


Michael Haude

Rotablation of LAD

18 May 2016 – From EuroPCR 2016

Panellists: M. Balghith, C. Cook, C. Dubois, A. Gershlick, J. Koolen and M. Strozzi

Consult the session video on rotablation of LAD with LIVE demonstration from St. Thomas' Hospital - London, United Kingdom.

Clinical Case

A 80-year-old male with inferior STEMI in March 2016:

PPCI of RCA is doneFFR measurement of LCX and LADRotablation of LAD

Expanding applications of iFR/FFR in clinical practice

22 May 2015 – From EuroPCR 2015

Romain Didier


Romain Didier